Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Drug-delivery pump implant for chronic pain firm raises $25 million

9:51 am by | 1 Comments

A company that got U.S. Food and Drug Administration approval for its drug-delivery pump for chronic pain, including back pain, earlier this year has raised $25 million to help market the pump in the U.S, according to a company statement.

The company has said it is the first evolution in the pump technology since a device from Medtronic (NYSE:MDT) hit the market 15 years ago.

The financing round for Flowonix, which recently changed its name from Medasys, reflected a mix of new and established investors. It was led by RFT Investment Co. in Atlanta, a new investor. Also joining its backers were OmniCapital Fund, a fund run by the New Jersey venture capital firm Omni Capital that focuses on early growth stage companies, and Clarus Ventures, who has previously invested in the company and is a dedicated life sciences venture capital firm with a long history of creating value across multiple disciplines.

The fresh capital will also help Mount Olive, New Jersey-based Flowonix develop its drug-delivery technologies.

Advertisement

The pump, which received approval from European regulators in December 2010, uses pressure differentials in order to optimize accurate drug delivery. The pump has no motors or tubing and few movable parts. It is implanted under the skin in the lower abdominal area with a catheter that goes from the pump to the spine. The pump is approved for the delivery of Infumorph, a morphine sulfate sterile solution.

A report published by the Institute of Medicine last year said about 100 million Americans suffer from chronic pain.

Flowonix was founded in 2005 and is led by Steve Adler. Before joining the company, Adler was the executive vice president at Transneuronix until it was acquired by Medtronic in 2005.

 

 

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author

1 comments
physicans
physicans

My husband has been in horrific pain the last several months, several doctors cannot find the cause for his drastic weight lose and pain.  He had a pain pump inserted a couple years ago, worked great, he faithfully had it checked and refilled when it was time.  He took a bad fall over a year ago, has much pain since then.  He was checked today by the pain consultant and we were told the catheter was broken and no medication was getting to his spine.  Is this something that should be checked especially since he's lost about 60 pounds and in horrible pain?

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement